|
|
|
|
| Initial public issue of 3000000 equity shares of face value of Rs. 10/- each of Sotac Pharmaceuticals Limited ("SPL" or the "Company" or the "Issuer") for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share (the "Issue Price") aggregating to Rs. 33.30 crores ("The Issue"), of which 150000 equity shares of face value of
Rs. 10/- each for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share aggregating to Rs. 1.67 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 2850000 equity shares of face value of Rs. 10/- each at a price of Rs. 111/- per equity share including a share premium of
Rs. 101/- per equity share aggregating to Rs. 31.63 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 27.15% and 25.79%, respectively, of the post issue paid up equity share capital of the company.
The face value of the equity shares is Rs. 10/- each.
|
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Application |
Allotment |
| 29-Mar-23 |
03-Apr-23 |
111.00-0.00 |
0.00-0.00 |
|
|
Minimum Application for shares in Nos : 1200
Further Multiples of : 1200
|
|
| |
Rs Cr |
Lead Managers to the Issue |
| Project Cost |
31.10 |
Beeline Capital Advisors Pvt Ltd
|
| Project Financed through Current Offer |
33.30 |
|
| Post Issue Equity Share Capital |
11.05 |
|
| Issue Price |
111.00 |
|
|